CD276 and cancer: Data in Fig. 6F, Additional file 1: Fig. S5C indicated that PDGFRB blockade inhibited the expression of immune checkpoint molecules in cancer cells, including IDO1, PD-L1, B7H3, B7H4, and Tim-3.